Home
Careers
Media
Contact us
Corporate Profile
Vision & Mission
History
Board of Directors
Certifications
Group Companies
Active Pharmaceutical Ingredients
Bulk Pharma Chemicals
Phosgene
Intermediates
Formulations
International
Domestic
Branded Formulations
Generic
Herbal Nutraceuticals
Veterinary
Contract / Collaborated Research Services
Alembic Research Center
Quality
Regulatory Affairs
Objectives
Activities
Macrolide Chemistry
Corporate Citizenship
Environment
Community
Corporate Overview
Letter from the Chairman
Stock Quote
Code of Conduct
Shareholding Pattern
Financial Results
Annual Report
Quarterly Reports
Events & Presentation
Investor Corner
Investor Presentation
Bifurcation of cost of Acquisition
Press Release
02nd May ,2013
Alembic Pharmaceuticals Limited announces its results for the Year ended 31st March 2013
21st Jan ,2013
Alembic Limited announces consolidated results for the 3rd Quarter ending in 31st Dec 2012 :
19th Oct ,2012
Alembic Pharmaceuticals Limited announces Consolidated Results for quarter ended 30th Sep 2012
09th Aug ,2012
Alembic Pharmaceuticals Limited announces Consolidated Results for quarter ended 30th Jun 2012
25th Apr ,2012
Alembic Pharmaceuticals Limited announces Consolidated Results for quarter ended 31st March 2012
19th Oct ,2011
Alembic Pharmaceuticals Limited announces Consolidated Results for quarter ended 30th Sept 2011
26th Jul ,2011
Alembic Pharmaceuticals Limited announces Consolidated Results for quarter ended 30th June 2011
02nd May ,2011
Alembic Pharmaceuticals Limited announces consolidated results for Quarter / Year ended 31-0-2011
10th Feb ,2011
Alembic Limited announces consolidated results for the 3rd Quarter ending in 31st Dec 2010 :
Media
News & Events
Press Release
Press Kit
Subscription